fda approval sought in multiple myeloma, 2017 aacr annual meeting highlights, and more
Published 7 years ago • 135 plays • Length 7:49
Download video MP4
Download video MP3
Similar videos
-
6:27
fda approval in myeloma, priority review in all, and 2017 gu cancers symposium highlights
-
10:23
fda approvals in hematologic malignancies, sbla accepted in multiple myeloma, and more
-
10:55
fda approval in myeloma, label update in her2 breast cancer, and more
-
10:49
fda approvals in myeloma, nets, and of a biosimilar, priority review in ovarian cancer, and more
-
10:08
fda approvals in myeloma and attp, priority review designations in rcc and hnscc, and more
-
10:47
fda approvals in myeloma and itp, applications accepted in myeloma and more
-
9:24
fda approvals in myeloma and head and neck cancer, and findings across several tumor types
-
9:02
fda approval in sarcoma, priority reviews in mcrpc and myeloma, and more
-
8:00
fda approval in rcc, european approvals in myeloma and melanoma, and 2016 aua highlights
-
12:53
fda approval in sclc, partial hold in myeloma trials, nccn guideline update in crc, and more
-
1:34
dr. anderson on recent fda approvals in multiple myeloma
-
10:00
fda approval in breast cancer, review period extended in aml, 2019 aacr highlights, and more
-
10:20
fda approvals in myeloma and thyroid cancer, priority review and nda in nsclc, and more
-
1:22:54
congressional briefing aacr cancer progress report 2017
-
7:44
fda approvals for daratumumab and osimertinib, regulatory advances in rcc and cll, and more
-
6:11
fda labels of new multiple myeloma agents
-
1:12
the recent fda approval of cilta-cel and its impact on myeloma patients in the uk
-
8:21
fda approval of a biosimilar, priority review in epithelioid sarcoma, and more
-
5:45
evolution of diagnostic and response criteria in multiple myeloma
Clip.africa.com - Privacy-policy